Director of Medical Affairs – COPD

📋 Description

• The U.S. Director of Medical Affairs (US DMA) for COPD is a key position within the Value & Implementation (V&I) organization, which encompasses Global Medical and Scientific Affairs as well as Outcomes Research.

• This role is pivotal in driving scientific excellence across both in-line products and the company's pipeline while enhancing field readiness in alignment with the USMA strategic pillars: 1) Scientific Exchange; 2) Company Trials; 3) Investigator-Sponsored Programs; 4) Congresses; and 5) Scientific Insights.

• The US DMA serves as a seasoned therapeutic area (TA) leader and subject-matter expert (SME), bringing essential medical affairs and field medical experience.

• This position is tasked with executing scientific and medical affairs plans for designated TAs within their region, collaborating with regional cross-functional teams, and contributing U.S. insights to relevant cross-functional team meetings such as the U.S. Medical Affairs Team (MAT), Payor Access Team (PAT), Management Team (MT), and V&I Plans.

• As a core member (or co-lead) of the U.S. MAT, the US DMA partners with the Global TA team and cross-functional colleagues to facilitate the U.S. implementation of V&I Planning by: incorporating local insights into Global Scientific Value Content (GSVC) and Center of Scientific Exchange Excellence (CSEE) plans.

• Promoting local adoption of GSVC and CSEE initiatives, and leading the development and execution of aligned local training programs.

• Assessing training effectiveness and its application in the field. Together with the USMA Executive Director (ED) and Health Systems Payor & Access Strategy Lead (HS PASL), the US DMA develops and implements regional strategies that align with headquarters V&I objectives, including defining a prioritized USMA Field strategy and implementation goals.

• Contributing to the integrated U.S. Country Medical Affairs Plan (CMAP), which includes the U.S. Field Medical Plan (FMP)/Field Engagement Plan (FEP), and field training plan for the COPD TA as a member of the USMA COPD Leadership Team.

• Identifying and prioritizing U.S. field resources, training needs, and activities; collaborating with V&I Global Medical & Value Capabilities (V&I GMVC) to ensure content and training are strategically aligned, including the execution of pre- and post-congress regional training and content pull-through.

• Crafting a strategic and comprehensive scientific engagement plan, ensuring that scientific exchange is in alignment with the global scientific communications platform.

• Ensuring that insights gathered from advisory boards and field medical activities are acted upon with relevant stakeholders, aligned with Country Medical Affairs priorities, and monitored for trends that could influence future strategies.

• In collaboration with pertinent USMA stakeholders (e.g., HS PASL), organizing expert input events (e.g., advisory boards, forums) with contracted scientific leaders and key stakeholders to address new indication implementation and/or emerging scientific advancements.

• Overseeing programs (i.e., patient support, education, risk management) as necessary to ensure the appropriate and safe use of company medications.

• Collaborating with GSVC, CSEE, U.S. Global Clinical Trial Organization (GCTO), V&I Global Medical and Scientific Affairs (V&I GMSA) COPD leads, and both internal and external SMEs to coordinate and deliver regional training as required.

• Engaging in bi-directional information exchange and sharing best practices across USMA roles and teams, including Health Systems.

• Partnering with the USMA Field Medical Alignment Director (FMAD) to ensure uniform standards, processes, and harmonization for training activities (e.g., clinical immersions, verbalizations, journal clubs).

• Providing input into strategic congress priorities and participating in planning for key scientific congresses.

• Continuously monitoring the healthcare environment and emerging trends to optimize CMAPs and field execution plans.

⛳️ Requirements

• An advanced degree (e.g., MD, PhD, PharmD) relevant to the specific TA disease area, coupled with recognized medical expertise in the TA.

• A minimum of five years of experience in medical affairs.

• At least three years of experience working in COPD (clinical, research, or pharmaceutical setting) or within a highly relevant TA, demonstrating scientific acumen.

• Proven capability in strategic decision-making and planning, including aiding the U.S. Executive Director in prioritizing initiatives across the portfolio.

• Demonstrated excellence in execution with a history of leading complex projects and managing multiple priorities in a fast-paced environment.

• An AI-first mindset, utilizing artificial intelligence (AI) tools and showing eagerness to learn and apply new methodologies, without necessarily having deep technical knowledge.

• Strong emotional intelligence, fostering trust and respect within a complex, matrixed organizational structure.

• Exceptional networking and partnership skills to collaborate effectively with various teams and stakeholders.

• An agile mindset as a change catalyst, committed to experimentation, learning, and adaptation in response to evolving business needs, capable of driving continuous improvement.

• Proficiency in interpreting and articulating complex scientific concepts clearly in both individual and group contexts.

• In-depth knowledge of the U.S. healthcare system, encompassing national treatment guidelines, clinical research processes, U.S. Food and Drug Administration (FDA) regulations, and Office of Inspector General (OIG) compliance.

• Willingness to travel up to 40% (e.g., for congresses).

🏝️ Benefits

• Medical, dental, vision healthcare, and other insurance benefits (for employee and family).

• Retirement benefits, including 401(k).

• Paid holidays, vacation, and compassionate and sick days.